Introducing SpectrumTM
AI-Optimized Feasibility to predict, optimize and control trial timelines and cost impacts, in real-time.
AI-optimized trials
Feasibility in minutes, not weeks
Spectrum™ harnesses the power of data and AI/ML to reduce the pain during the feasibility process in clinical trials. Designed for pharmaceutical sponsors and CRO’s, Spectrum offers a quick and accurate analysis for enrollment timelines and scenario planning to navigate and optimize for the constraints of time, cost, site selection and country choices to meet enrollment objectives based upon specific inclusion and exclusion criteria.
- Identify the right sites and country combinations
- Create, adjust, and compare study scenarios in real-time
- Predict enrollment timelines, study costs and understand the optimal site/country activation sequence for improved odds-of-success
Predict
Spectrum™ brings the power of prediction to your clinical trials, ensuring that every phase is backed by data-driven confidence. Elevating certainty in resource planning and cost management, guiding you for study success by accurately forecasting timelines and costs.
Optimize
Study teams can easily navigate the complexities of clinical trials by optimizing their trial with real-time scenario analysis, forecasting that minimizes guesswork, and ensuring that each trial is optimally designed for efficiency, from strategic groundwork to mid-study pivots.
Control
Spectrum™ empowers study teams with unparalleled control and real-time insights over their clinical trial. The heightened command over trial variables ensures that teams can proactively manage changes in design, supply, and site activation with agility and precision.
Spectrum helps you optimize planning and operations across the Clinical Trial value chain...
Strategic Feasibility
Accurately identify the right sites and country combination with odds of success for different scenarios.
Study Duration ForecastingSee your study and enrollment forecasted timelines and the odds of successfully meeting your enrollment target
Scenario planningAdjust and compare study plans in real-time
BenchmarkingSee how your predicted study plan compares to historical studies
Budget ForecastingEnter site activation and site maintenance costs and optimize budget and timeline scenarios
Operational Feasibility
Drive intelligent site startup sequencing, drug supply, and impact assessments.
Site Startup SequencingLeveraging regulatory approval, startup and enrollment data, determine the best sequencing of site activation to drive continuous enrollment
Drug SupplyOptimize drug supply needs per country and site based on study forecasts
Impact AssessmentsSimulate timeline and cost impact of adding countries and sites
Mid-study Feasibility
Optimize your study plan in real-time with daily re-forecasting of enrollment, screening, and site performance.
Predict and control enrollment timelines and IP needs based on actual enrollment and screening data to answer your questions in real-time to get an updated odds of success.- Will I hit my enrollment target with a 90-day extension?
- What is the timeline and cost impact of a delayed country approval?
- What if I add 5, 10, or 20 more sites? How will that impact my trial?
.
Try it out today
Spectrum is trusted by top-10 pharma sponsors to accurately predict trial timelines, identify sites and country combinations for optimal study performance.
Get your Free On-Demand Feasibility assessment in 5 business days.
Case Study
Strategic Feasibility for top-10 Sponsor
A comprehensive feasibility analysis, including Real-World Data (RWD)-driven patient-finding, was conducted for a top-10 Pharmaceutical Sponsor. The analysis provided two scenarios for the trial based on different sets of inputs.
Impact
- Validated initial feasibility timeline was within 85% confidence interval
- Recommended alternative scenario’s that decreased timeline and improved odds-of-success
- Identified competitor (drug x) sites and overlap – leading to potential enrollment issues
- Identified country & site opportunities not previously planned to improve odds-of-success
- Included countries with strong enrollment rates relative to the USA for Phase III TA-specific (e.g., Denmark)
- De-risked from potential over-concentration in the United States
What makes Spectrum different
Real-Time Data
View all your relevant study data in real-time through a consolidated dashboard.
Increased Confidence
Enrollment Insights
Operational Efficiency
Benchmark trial performance against Lokavant's proprietary data to optimize your resources and reduce study team burden.
Participant Safety
View participant safety data in real-time across all sources through a consolidated dashboard that enables you to quickly monitor safety trends.
Ensure DEI Compliance
Monitor your DEI plan and ensure your trial is representative of the patient population to meet regulatory compliance.
Predictive Notifications
Predictive notifications become available in Lokavant's Clinical Trial Intelligence platform and helps identify potential risks before they become issues.
Connect Dashboards
All your study operational data through a connected dashboard that eliminates the need for time-consuming manual data aggregation.
Resources
How decentralized approaches mitigate enrollment challenges
Lokavant partnered with THREAD to conduct the first-ever impact analysis of DCTs on key performance indicators during the pandemic.
From wrong to 95% right
Learn how to predict key enrollment outcomes earlier in a study's trajectory and with 95% accuracy.
Predictive factors of clinical trial participant discontinuation
Expert analysis that investigates the key predictive factors that increase and decrease risk of participant discontinuation.
Oversight indicators & benchmarks for your clinical trial
Discover how to unlock the power of data-driven foresight in clinical trials, make better decisions to prevent quality issues, and optimize study performance with Lokavant's valuable insights and indicators.
FAQs
What is Lokavant, and how can it benefit my clinical trials?
Lokavant is the leading Clinical Trial Intelligence platform that supports data collection, understanding, and application for clinical research. It empowers study teams to make informed decisions, improve trial performance, and streamline workflows. Real-time study health reports ensure that Sponsors, CROs, and Sites are synchronized and make decisions based on accurate insights.
What specific technologies does Lokavant offer for clinical trials?
Lokavant provides analytics solutions designed to enhance Clinical Trial Performance. Our core product, Prizm™ CDH, consolidates and standardizes trial data in real-time. Using AI & ML, we provide actionable insights throughout your trial life-cycle, from planning to risk detection, and even DEI oversight.
Lokavant's recent launch of SpectrumTM harnesses the power of data and AI/ML to reduce the pain during the feasibility process.
Designed for pharmaceutical sponsors and CRO’s, Spectrum offers quick and accurate analysis for enrollment timelines and scenario planning to navigate and optimize for the constraints of time, cost, site selection and country choices to meet enrollment objectives based upon specific inclusion and exclusion criteria.
What exactly is Clinical Trial Intelligence?
Clinical Trial Intelligence takes traditional analytics and informatics a step further. While traditional methods involve the collection and analysis of data, our Clinical Trial Intelligence uses AI and ML to understand and apply data. This empowers stakeholders to make informed decisions in real-time, optimize resources, and accelerate the development of therapies.
Lokavant levereages AI/ML in their most advanced forms that include predictive, prescriptive and causal-AI to empower study teams to glean insights in real-time.
What services can Lokavant provide for my team?
Lokavant offers comprehensive project management, delivery services, personalized training, system integrations, and ongoing support for each study. Our team stays with your study from start to finish, ensuring you get the maximum value from the Lokavant platform.